SUVENPHAR.NS Shariah Compliance

Screening Methodology: AAOIFI

lock image
LOCKED

Analyst's Ratings for Suven Pharmaceuticals Ltd (SUVENPHAR.NS)

Based on 10 analysts giving stock ratings to Suven Pharmaceuticals Ltd in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
40
Buy
50
Hold
10
Sell
0
Strong Sell
0
Suven Pharmaceuticals Ltd

Suven Pharmaceuticals Ltd. Stock Analysis SUVENPHAR.NS

India Health Care Mid Cap Report:
Suven Pharmaceuticals Ltd. manufactures chemical products. The company is headquartered in Rangareddi, Telangana and currently employs 1,052 full-time employees. The company went IPO on 2020-03-09. The firm is engaged in the business of contract development and manufacturing organization (CDMO). The company is primarily engaged in the business of development and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies. The firm operates through manufacturing (CRAMS) - bulk drugs & intermediates under contract services products are developed and produced on an exclusive basis under contract manufacturing services. Its geographical segments include India, the USA, Europe, and the Rest of the world. Its manufacturing capabilities for NCEs include real-time formulation development support for adaptive clinical trials and reduced production costs with novel dosage forms that minimize R&D iteration.
Read More

Suven Pharmaceuticals Ltd (SUVENPHAR.NS) Chart

Suven Pharmaceuticals Ltd (SUVENPHAR.NS) vs Nifty 50 Comparative Returns

Analysis of Suven Pharmaceuticals Ltd (SUVENPHAR.NS) stock performance compared to the broader market (Nifty 50) across multiple timeframes.

YTD Performance
  • Suven Pharmaceu... (SUV...) -11.05%
  • Nifty 50 3.1%
Suven Pharmaceu... Underperformed Nifty 50 by 14.15%
1Y Performance
  • Suven Pharmaceu... (SUV...) -15.24%
  • Nifty 50 -2.68%
Suven Pharmaceu... Underperformed Nifty 50 by 12.56%
3Y Performance
  • Suven Pharmaceu... (SUV...) 112.09%
  • Nifty 50 37.83%
Suven Pharmaceu... Outperformed Nifty 50 by 74.26%
5Y Performance
  • Suven Pharmaceu... (SUV...) 201.32%
  • Nifty 50 110.16%
Suven Pharmaceu... Outperformed Nifty 50 by 91.16%

Key Statistics of Suven Pharmaceuticals Ltd (SUVENPHAR.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹914.25₹1,038.90

Today's Open

₹937.70

Volume

4.94M

P/E Ratio (TTM)

138.27

52 Week Range

₹856.30₹1,360.00

Market Cap

413.36B

Avg. Volume

726.73K

Dividend Yield

-

Financial Metrics & Statements of Suven Pharmaceuticals Ltd (SUVENPHAR.NS)

FAQ's for Suven Pharmaceuticals Ltd (SUVENPHAR.NS)

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.